2023 - Research.com Immunology in United States Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Immunology in United States Leader Award
2010 - Fellow of the American Academy of Arts and Sciences
2009 - Member of the National Academy of Medicine (NAM)
2004 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
Bruce D. Walker mainly focuses on Immunology, Virology, Virus, Cytotoxic T cell and Epitope. His study in Human leukocyte antigen, Immune system, Viral load, Viremia and CD8 is carried out as part of his Immunology studies. His Virology research is multidisciplinary, incorporating perspectives in T cell, Antibody, CTL* and Antigen.
His work deals with themes such as Mutation and Cellular immunity, which intersect with Virus. The various areas that he examines in his Cytotoxic T cell study include Molecular biology and Major histocompatibility complex. His study in Epitope is interdisciplinary in nature, drawing from both Antigen processing, HIV Antigens, Histocompatibility and Group-specific antigen.
His primary scientific interests are in Immunology, Virology, Cytotoxic T cell, Immune system and Virus. His Immunology study is mostly concerned with Viral load, CD8, T cell, Viremia and Antibody. He interconnects Epitope, Human leukocyte antigen, Antigen and CTL* in the investigation of issues within Virology.
The study incorporates disciplines such as Viral evolution and Allele in addition to Human leukocyte antigen. His biological study spans a wide range of topics, including Molecular biology and Major histocompatibility complex. His Immune system research includes elements of HIV vaccine and Cytokine.
Bruce D. Walker focuses on Immunology, Virology, Immune system, Cytotoxic T cell and CD8. His is involved in several facets of Immunology study, as is seen by his studies on Antibody, T cell, Viral load, Viremia and Viral replication. His Virology research is mostly focused on the topic Virus.
Bruce D. Walker focuses mostly in the field of Immune system, narrowing it down to topics relating to Downregulation and upregulation and, in certain cases, Viral pathogenesis. The Cytotoxic T cell study combines topics in areas such as Acquired immune system and Interferon. His CD8 research is multidisciplinary, incorporating elements of Lentivirus, Molecular biology, HIV vaccine and T-cell receptor.
His scientific interests lie mostly in Immunology, Virology, Immune system, Viremia and Antibody. His work deals with themes such as Young adult and Receptor, which intersect with Immunology. His Virology research incorporates elements of Epitope, Antigen and Effector.
His research investigates the link between Immune system and topics such as Cytotoxic T cell that cross with problems in Acquired immune system, T cell, Human leukocyte antigen and Major histocompatibility complex. The study incorporates disciplines such as Downregulation and upregulation and Viral replication in addition to Viremia. His study looks at the relationship between CD8 and topics such as HIV vaccine, which overlap with Bystander effect.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hepatitis C Virus Infection
Georg M. Lauer;Bruce D. Walker.
The New England Journal of Medicine (2001)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L Day;Daniel E Kaufmann;Photini Kiepiela;Julia A Brown.
Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Diana Finzi;Joel N Blankson;Janet M Siliciano;Joseph Bernard Margolick.
Nature Medicine (1999)
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
Eric S. Rosenberg;James M. Billingsley;Angela M. Caliendo;Steven L. Boswell.
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
F. Lechner;D. K. H. Wong;P. R. Dunbar;R. Chapman.
Journal of Experimental Medicine (2000)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
Kathleen L. Collins;Benjamin K. Chen;Spyros A. Kalams;Spyros A. Kalams;Bruce D. Walker;Bruce D. Walker.
Immune control of HIV-1 after early treatment of acute infection
Eric S. Rosenberg;Marcus Altfeld;Samuel H. Poon;Mary N. Phillips.
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
Johannes F. Scheid;Hugo Mouquet;Beatrix Ueberheide;Ron Diskin.
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Photini Kiepiela;Kholiswa Ngumbela;Christina Thobakgale;Dhanwanthie Ramduth.
Nature Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: